MCAM and prostate cancer: 2. Human METCAM (huMETCAM) Is Overly Expressed in Prostate Cancer Tissues and in TRAMP, Suggesting That It May Serve as a Biomarker for Predicting the Malignant Potential of Prostatic Tumors